{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T16:06:41Z","timestamp":1765728401793,"version":"3.44.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.amjmed.2009.05.017","type":"journal-article","created":{"date-parts":[[2010,3,3]],"date-time":"2010-03-03T04:44:47Z","timestamp":1267591487000},"page":"275-280","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Adoption of Once-monthly Oral Bisphosphonates and the Impact on Adherence"],"prefix":"10.1016","volume":"123","author":[{"given":"Becky A.","family":"Briesacher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan E.","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leslie R.","family":"Harrold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassan","family":"Fouayzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Yood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2009.05.017_bib1","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1359\/JBMR.040325","article-title":"Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis","volume":"19","author":"Chesnut","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.amjmed.2009.05.017_bib2","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1007\/s00198-004-1602-9","article-title":"Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study","volume":"15","author":"Delmas","year":"2004","journal-title":"Osteoporos Int"},{"year":"2005","series-title":"Boniva Product Labeling","key":"10.1016\/j.amjmed.2009.05.017_bib3"},{"key":"10.1016\/j.amjmed.2009.05.017_bib4","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1359\/JBMR.050313","article-title":"Monthly oral ibandronate therapy in postmenopausal osteoporosis: 1-year results from the MOBILE study","volume":"20","author":"Miller","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.amjmed.2009.05.017_bib5","doi-asserted-by":"crossref","first-page":"856","DOI":"10.4065\/80.7.856","article-title":"Effect of dosing frequency on bisphosphonate medication adherence in a large longitudinal cohort of women","volume":"80","author":"Recker","year":"2005","journal-title":"Mayo Clin Proc"},{"issue":"4 Suppl 1","key":"10.1016\/j.amjmed.2009.05.017_bib6","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.amjmed.2005.12.018","article-title":"Persistence with bisphosphonate treatment for osteoporosis: finding the root of the problem","volume":"119","author":"Cramer","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.amjmed.2009.05.017_bib7","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1185\/030079905X61875","article-title":"Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis","volume":"21","author":"Cramer","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.amjmed.2009.05.017_bib8","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1001\/archinte.165.20.2414","article-title":"Compliance with osteoporosis medications","volume":"165","author":"Solomon","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjmed.2009.05.017_bib9","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1001\/archinte.167.6.540","article-title":"Interventions to enhance medication adherence in chronic medical conditions: a systematic review","volume":"167","author":"Kripalani","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjmed.2009.05.017_bib10","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1185\/030079906X154042","article-title":"Patient preference and adherence: comparative US studies between two bisphosphonates, weekly risedronate and monthly ibandronate","volume":"22","author":"Gold","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.amjmed.2009.05.017_bib11","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1185\/030079905X74862","article-title":"Patient preference for once-monthly ibandronate versus once-weekly alendronate in a randomized, open-label, cross-over trial: the Boniva Alendronate Trial in Osteoporosis (BALTO)","volume":"21","author":"Emkey","year":"2005","journal-title":"Curr Med Res Opin"},{"year":"2005","series-title":"Health Research Data for the Real World: The MarketScan Databases","author":"Adamson","key":"10.1016\/j.amjmed.2009.05.017_bib12"},{"year":"2006","series-title":"MarketScan Research Databases User Guide and Database Dictionary","key":"10.1016\/j.amjmed.2009.05.017_bib13"},{"key":"10.1016\/j.amjmed.2009.05.017_bib14","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S0895-4356(01)00480-2","article-title":"Validation of diagnoses of peptic ulcers and bleeding from administrative databases: a multi-health maintenance organization study","volume":"55","author":"Andrade","year":"2002","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.amjmed.2009.05.017_bib15","first-page":"7","article-title":"Using diagnoses to describe populations and predict costs","volume":"21","author":"Ash","year":"2000","journal-title":"Health Care Financ Rev"},{"issue":"6 Pt 2","key":"10.1016\/j.amjmed.2009.05.017_bib16","first-page":"180","article-title":"Measuring population health risks using inpatient diagnoses and outpatient pharmacy data","volume":"36","author":"Zhao","year":"2001","journal-title":"Health Serv Res"},{"key":"10.1016\/j.amjmed.2009.05.017_bib17","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/j.1742-1241.2006.01059.x","article-title":"Treatment persistence with once-monthly ibandronate and patient support vs once-weekly alendronate: results from the PERSIST study","volume":"60","author":"Cooper","year":"2006","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.amjmed.2009.05.017_bib18","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1185\/030079907X226069","article-title":"Persistence across weekly and monthly bisphosphonates: analysis of US retail pharmacy prescription refills","volume":"23","author":"Weiss","year":"2007","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.amjmed.2009.05.017_bib19","first-page":"31","article-title":"Women with postmenopausl osteoporosis express a preference for once-monthly ibandronate versus once-weekly bisphosphonate treatment","volume":"30","author":"Simon","year":"2005","journal-title":"Female Patient"},{"key":"10.1016\/j.amjmed.2009.05.017_bib20","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.bone.2007.07.009","article-title":"Consequences of poor compliance with bisphosphonates","volume":"41","author":"Briesacher","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.amjmed.2009.05.017_bib21","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s00198-003-1502-4","article-title":"Compliance with pharmacologic therapy for osteoporosis","volume":"14","author":"Yood","year":"2003","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.amjmed.2009.05.017_bib22","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0002-9343(03)00362-0","article-title":"Early discontinuation of treatment for osteoporosis","volume":"115","author":"Tosteson","year":"2003","journal-title":"Am J Med"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934309006597?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934309006597?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T08:52:27Z","timestamp":1757580747000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934309006597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0002934309006597"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2009.05.017","relation":{},"ISSN":["0002-9343"],"issn-type":[{"type":"print","value":"0002-9343"}],"subject":[],"published":{"date-parts":[[2010,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adoption of Once-monthly Oral Bisphosphonates and the Impact on Adherence","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2009.05.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}